[Effectiveness of taxol in head-neck tumors].
Schalhorn
B
B
D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000401:mortality; D003131:Combined Modality Therapy; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D017239:Paclitaxel / Q000009:adverse effects / Q000627:therapeutic use*; D015996:Survival Rate
D017239:Paclitaxel
Effektivität von Taxol bei Kopf-Hals-Tumoren.